Page last updated: 2024-10-26

enflurane and Glycogen Storage Disease Type I

enflurane has been researched along with Glycogen Storage Disease Type I in 1 studies

Enflurane: An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate.
enflurane : An ether in which the oxygen atom is connected to 2-chloro-1,1,2-trifluoroethyl and difluoromethyl groups.

Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casson, H1

Other Studies

1 other study available for enflurane and Glycogen Storage Disease Type I

ArticleYear
Anaesthesia for portocaval bypass in patients with metabolic diseases.
    British journal of anaesthesia, 1975, Volume: 47, Issue:9

    Topics: Anesthesia, General; Chemical Phenomena; Chemistry; Child; Child, Preschool; Enflurane; Female; Glyc

1975